8/8/2024, 12:47:02 pm

Sources accesses USFDA observations for Biocon Biologics unit

CNBC-TV18 has accessed the observations that the USFDA has issued to Biocon Biologics' Units. 📌Procedures designed to prevent microbiological contamination of drug products purporting to be sterile. 📌Procedures designed to prevent microbiological contamination of drug products purporting to be sterile not followed. 📌Lab tests procedures and controls are not established and followed.